Plex affiliate program
All your affiliate program data in one place
One dashboard to track Transactions - Revenues - Clicks - Payments with Strackr.com
Try for free
The Open Study College affiliate program offers your site visitors an opportunity to achieve their career goals and thrive in life. This platform for higher learning has been lauded as an authority for distance learning, with a family of over 100,000 learners. This program offers a 60-day cookie duration.
Whether you're a busy professional, a student seeking supplemental online learning, or an individual looking to acquire new skills, Study.com is your go-to hub for educational resources. As an established brand, Study.com has transformed the world of online education by offering access to high-quality, affordable, and flexible online courses, study guides, and comprehensive learning materials. This program offers a 7-day cookie duration.
Study Plex is a leading training provider providing learning and development opportunities to entertain and educate our learner base through modern learning technology. This program offers a 15-day cookie duration.
Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $74 per visit for time and travel. Study Description: The purpose of the APATURA study is to see how effective an investigational medication is at helping to treat Systemic Lupus Erythematosus (SLE). You may be asked to attend 1 screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive the first dose of medication being tested in this study intravenously (through an IV), then the medication will be given as injections every 2 weeks for 6 months. Your total participation will last approximately 10 months and you will be asked to attend two study visits per month during the treatment period and once per month during the follow-up period. You will have the possibility of performing some of these visits remotely from your home, replacing physical office visits. During these visits, you will complete various diagnostic and laboratory tests. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $74 per visit for time and travel. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
You can become a certified Usui Reiki Master in as little as just 24 hours with the number one Reiki Master home study course, which includes Reiki 1, 2, Master Certification, and Distant Attunements.
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Doctor must have already diagnosed you with asthma for at least one year - Must currently use a daily inhaler that contains a corticosteroid? Examples include: Flovent HFA, Pulmicort, Qvar, Advair, Breo, Dulera, Azmacort. Rescue inhalers such as albuterol should not be counted. - In the past year, must have had an asthma exacerbation (a worsening of symptoms) that required: Treatment with systemic (oral, IV, injectable) corticosteroids for at least 3 days or Led to an emergency room/urgent care visit or hospitalization - Cannot also be diagnosed with the following: Cystic fibrosis, Pulmonary fibrosis, Chronic obstructive pulmonary disease (COPD), Emphysema - Cannot currently smoke Study Description: The purpose of this clinical study is to test if the use of an approved asthma medication, dupilumab, can preserve long term lung function in people with moderate to severe asthma. If you are eligible, you will be asked to attend a screening visit to determine if you can enroll in the study. If enrolled, you will receive either dupilumab or placebo to be given as an injection once every 2 weeks for 3 years. You will have a 2:1 chance of being assigned dupilumab versus the placebo. The study medication will be given alongside current standard of care asthma therapy. Your total participation will last approximately 3 years and 4 months and you will be asked to attend 15 doctor’s visits. During these visits, you will complete various diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated for time and travel.
Conversion Point: Valid Form Fill Ages: 6-11 Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $675 for their time and reimbursed for travel expenses.. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Child must be between the ages of 6-11 years old - At least 10% of child's body must be affected with eczema (that is approximately the surface of one entire arm (front and back)) - Child cannot have taken Adbry (tralokinumab) within the last 4 months - Child cannot be currently receiving allergy shots - Child cannot have asthma Study Description: The purpose of this clinical study is to see how effective an investigational injectable medication is at helping to treat moderate to severe atopic dermatitis (eczema) in children and adolescents. You and your child will be asked to attend up to 2 screening visits to determine if they are eligible to enroll in the study. As part of the screening process, all participants will be instructed to use a topical corticosteroid (TCS) on areas affected by eczema, once daily, for 2 weeks. If eligible to participate, your child will receive injections of either the study drug or a placebo every 2 to 4 weeks while continuing to apply the steroid cream. Your child’s total participation will last approximately 8 months and you and your child will be asked to attend 10 further doctor’s visits. During these visits, he/she will complete various diagnostic and laboratory tests. After completing the study’s treatment period, your child may be eligible to partake in an open-label study, in which all participants receive the study medication. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $675 for their time and reimbursed for travel expenses. The doctor’s office conducting the study will be able to provide you and your child with more information about the study requirements.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Patient Profile / Filters: Gender: Any Ages: 18+ Study Description: A research study is looking to test the safety and effectiveness of an investigational medication for the treatment of Clostridioides difficile infection, also known as C. Diff infection or CDI. You may be eligible to participate immediately if you currently have active symptoms of C. Diff infection (diarrhea three or more times a day).
Conversion Point: Valid Form Fill Age Range: 16-40 Gender: Women Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1,842 for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - You (or your child) cannot have been diagnosed with a confirmed or suspected immunosuppressive or immunodeficient conditions – these include B cell deficiency, T cell deficiency, and HIV - Cannot have been diagnosed with an autoimmune disorder, including: o Crohn’s disease o Ulcerative colitis o Lupus o Type 1 Diabetes o Multiple Sclerosis o Rheumatoid Arthritis o Psoriasis - You (or your child) cannot have used an oral immunosuppressant such as prednisone for 14 consecutive days or longer in the last six months - Cannot have received any blood products in last three months - This study requires all participants to use a highly effective form of birth control for the first 9 months of study participation. Would you (would your child) be willing to avoid pregnancy by using either hormonal contraception or sexual abstinence? Study Description" The purpose of this clinical study is to see how effective an investigational vaccine is at preventing Cytomegalovirus (CMV) infection. You (your child) may be asked to attend 1 screening visit to determine if you (they) are eligible to enroll in the study. If enrolled, you (your child) will receive either the investigational vaccine being tested in this study or a placebo as 3 doses over 6 months. Your (your child’s) total participation will last approximately 2.5 years and you (they) will be asked to attend 13 doctor’s visits and at least 5 phone visits. During these visits, you (they) will complete various diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1,842 for time and travel.
Conversion Point: Valid Form Fill Age Range: 40-99 Gender: Any Reach: 30% of the US population Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $85 per visit for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must be diagnosed with COPD and chronic bronchitis for one year or longer - Must be treating your COPD using regular maintenance triple therapy (an inhaled corticosteroid (ICS), an inhaled LABA (a type of bronchodilator), and an inhaled LAMA (a type of bronchodilator) - Must have experienced a COPD exacerbation within the past year that required you to visit an ER and/or receive treatment with steroids or antibiotics - For current or former smokers - Cannot have a history of the following lung diseases: pulmonary fibrosis, cystic fibrosis, alpha 1 anti-trypsin deficiency, interstitial lung disease Study Description: This is a clinical research study to test the safety and effectiveness of an investigational medication as an add-on treatment for Chronic Obstructive Pulmonary Disease (COPD). You may qualify to participate if you have been diagnosed with COPD, are currently prescribed triple maintenance therapy and have had at least one exacerbation in the past year. You may be asked to attend up to two screening visits to determine if you are eligible to enroll in the study. If enrolled, you will be randomly selected to receive either the investigational medication, an approved oral medication (known as roflumilast, marketed as Daliresp), or a placebo to be taken daily for one year. Study-provided medication will be taken alongside your current triple COPD medications and rescue therapy will be available as needed. Your total participation will last just over 1 year (56 weeks), and you will be asked to complete 2 phone calls and attend up to 8 doctor's visits throughout the study. You will complete various diagnostic and laboratory tests during your visits, and you will be asked to complete daily questionnaires in an e-diary to evaluate your COPD symptoms. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $85 per visit for time and travel.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: Diagnosed with Type 2 Diabetes Cannot be receiving dialysis Cannot have a history of heart or liver failure Cannot be on blood thinners Diabetic kidney disease (diabetic nephropathy) is a common complication of type 1 and type 2 diabetes. Over time, poorly controlled diabetes can cause damage to blood vessel clusters in your kidneys that filter waste from your blood. This can lead to kidney damage and cause high blood pressure. Study Description: The purpose of this clinical study is to see how effective an investigational injectable cell therapy is at helping to treat diabetic kidney disease. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will be randomly assigned to one of two groups. One group will undergo a kidney biopsy. The study team will prepare the investigational product from the biopsy tissue. You will then receive one injection of your own highly concentrated kidney cells into each kidney, three months apart. The second group will undergo simulated procedures for the biopsy and the injections, meaning that the procedure will be mimicked, but no actual tissue is extracted and reinjected. You will not know which group you are in while participating in the study. Your total participation may last up to 5 years. You will be asked to attend 16 office visits in the first 6 months and then follow-up visits every 3 months until the study ends. During these visits, you will complete various procedures, diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
The user needs to complete and be approved in the research study. Accepts: email and display Target: Zip Codes: 60313/44787/04103/12627/65185 Patient Profile • Male or Female, aged 18+ • Reports history of pain in the knee or hip • Body mass index (BMI) less than or equal to 39
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1250 for your participation, time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must have had one of the following: A: Heart attack B: Heart revascularization procedure C: Stroke D: Carotid artery (neck) revascularization procedure E: Peripheral artery (leg) revascularization procedure F: Lower leg amputation due to peripheral artery disease - Must be taking medications to lower your cholesterol or lipid levels
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $50 per visit for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must be diagnosed with high blood pressure by your doctor for at least 6 months - Your blood pressure must be high even when taking your medication Study Description: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat high blood pressure. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken once daily for approximately 3 months. You will be required to take a standardized regimen of anti-hypertension medication as directed by the study physician alongside the study drug or placebo. Total participation could last up to 19 weeks, and you may be asked to attend 9 doctor’s visits. During these visits, you will complete various diagnostic and laboratory tests. Following the initial 3-month treatment period, you may be given the option to enter an open label extension period where all participants will receive the study drug. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $50 per visit for time and travel. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Ages:18-75 Gender: All Study Description: The purpose of this clinical study is to determine whether an investigational oral medication can help to treat hypothyroidism. You may qualify to participate if you are currently taking the medication levothyroxine. If enrolled, you will be randomly selected to receive either the medication being tested in this study or an FDA approved thyroid medication to be taken once a day for up to 7 months (30 weeks). Total participation will last approximately 10 months (42 weeks) and you will be required to attend doctor’s visits every 6 weeks throughout the study. At the end of the 7-month treatment period, you will have the option to enroll in an open label extension period where you would take the study medication for up to 6 additional months. The doctor’s office conducting the study will be able to provide you with more information about the study requirements and you can discuss the optional extension if you have any questions. Trial-related procedures, study medication and transportation expenses will be covered at no cost to you. - Must have a diagnosis of hypothyroidism and be taking medication as thyroid replacement therapy for 6 months or longer - Cannot have had thyroid surgery within the last year - Cannot have had your thyroid removed - Cannot have had thyroid cancer or gastric bypass surgery or gastric sleeve surgery
Логомашина учит — это школа профессий, где образование встречает инновации. Наша миссия – обеспечить специалистов и начинающих профессионалов качественным и доступным образованием, отвечающим современным требованиям рынка труда. Мы предлагаем разнообразные образовательные продукты, включая цифровой дизайн, графический дизайн, SMM, селф-маркетинг, дизайн интерьеров, программирование, диетология, нутрициология и нейросети. Входим в топ-5 лучших школ с точки зрения продукта и образовательного результата и широко известны среди профессиональных дизайнеров. Имеем более 290 тысяч зарегистрированных пользователей и более 100 тысяч членов нашего комьюнити. Больше 60% студентов доходят до конца обучения, а 96% окончивших курс достигают своих целей. Онлайн курсы по граф дизайну, веб-дизайну, UX-UI дизайну, иллюстрации. На курсах 70% практики и 30% теории.
Open Study College provide online courses and accredited qualifications for adults, designed to be studied at home with full remote tutor support. Whether someone is looking to get to university or retrain for a new career, we can help.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Age Range: 40-80 Gender: All Study Description: The TemPo studies are evaluating the efficacy and safety of an investigational drug for Parkinson’s Disease. If you are interested in participating, you will be asked to attend a screening visit to determine your eligibility to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken once daily for 6 months, alongside your current medication (if any). Following the Study Treatment Period, you will have the option to participate in an Open-label Extension Study where you are guaranteed to receive the active study drug. Total study duration, (not including the Open Label Extension Period), is approximately 27 weeks with 12 office visits. The doctor’s office conducting the study will be able to provide you with more information about the study requirements Participants who qualify for the study will receive the study drug, study-related consultation and care, study visits tests, assessments and procedures at no cost, and may be compensated for their time and travel expenses. Qualifications: - Must be diagnosed with Parkinson’s Disease LESS than 3 years ago - Symptoms have gotten worse since diagnosis - Cannot have previously undergone a surgical procedure for Parkinson's Disease (example: deep brain stimulation) - Cannot have a history of brain tumor, epilepsy, or seizures - In the past year, have you had any hallucinations or episodes of psychosis for which you had to consult with a psychiatrist? (answer NO) - Cannot have had a heart attack in the past year - No cancer in last 5 years
Portrait My Pets lets you turn your pet into custom art, apparel, or merchandise. Each piece is thoughtfully designed to celebrate your pet’s personality in a way that feels personal and lasting.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Ages: 18+ Gender: All Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost. Additionally, travel costs may be reimbursed, the site will discuss this with you. Study Description: The purpose of this clinical study is to see how effective an investigational topical medication is at helping to treat nerve pain after a surgical procedure - also known as chronic post-surgical neuropathic pain. Post-operative nerve pain is common after many different operations and is normally located around the incision area. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the topical medication being tested in this study (which is currently on the market for use in other indications), or a low dose medication (which looks like the study medication but contains a much lower concentration of the active medication) that is currently not on the market. Both options are an adhesive wearable patch that would be applied to your skin for 60 min at different timepoints during the study. Your total participation will last approximately 10 months and you will be asked to attend several in person visits over the course of the study. During these visits, you will complete various diagnostic and laboratory tests. The medical office conducting the study will be able to provide you with more information about the study requirements. Participants who qualify for the study will receive trial-related procedures and study medication at no cost. Additionally, travel costs may be reimbursed, the site will discuss this with you. - Pain cannot be result of an amputation surgery, back-surgery due to back-pain, or surgery due to nerve compression repair - Pain symptoms must be from the last 6 months - 5 years - Pain scale from be 4 out of 10 - Can be taking opioid medication to manage pain, but study will require you to stop - Cannot currently be part of a lawsuit due to chronic pain or disability
Conversion Point: Valid Form Fill Ages: 18+ Gender: Any GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Have you been diagnosed with psoriatic arthritis (PsA) for 3 months or longer (answer: Yes) - Do you have active plaque psoriasis lesions or a history of plaque psoriasis (answer: Yes) - Have you ever taken medication to treat your PsA? (includes current and past use) (answer: Yes) - Have you ever taken a TNF-alpha inhibitor to treat your PsA? Examples include: - Cimzia (certolizumab) Enbrel (etanercept) Humira (adalimumab) Remicade (infliximab) Simponi (golimumab) (answer: yes or unsure) - Have you been diagnosed with any of the following conditions? - Lupus - Multiple Sclerosis - Rheumatoid Arthritis - Gout - Lyme disease (answer: No) Study Description: The purpose of this clinical study is to see how effective an investigational medication is at helping to treat psoriatic arthritis. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the study medication, a placebo, or an FDA-approved medication (apremilast) to be taken twice daily for four months. After four months, participants receiving the placebo option will be re-assigned to the study drug or apremilast and all participants will continue taking their medication for an additional 8 months. Your total participation will last approximately 14 months and will include regular doctor’s visits for follow-up care and testing. After the initial treatment portion of the study, there will be an opportunity for participants to join an optional open label extension period where they will take the investigational study drug for an additional 2 years. The doctor’s office conducting the study will be able to provide you with more information about the study requirements and the optional open label extension period. Participants who qualify for the study will receive trial-related procedures and study medication (or placebo) at no cost and may be compensated for time and travel.
The user needs to complete and be approved in the research study. Patient Profile- Male or Female, 18-85- High risk for Cardiovascular Disease- High risk for High Cholesterol and/or Diabetes Accepts: display target zip codes: 7130/0184/0122/02196/07580/01724
Study.com is an online education platform offering a vast array of academic resources.
Our Affiliate Program rewards partners for promoting our services.
Everyone deserves the life-changing impact of education. Breakthroughs Start Here.
We do not allow trademark bidding.
We do not allow trademark plus bidding.
We do not allow paid search direct linking.
We allow certain downloadable software partners to join our program.
We allow email marketing. All partners must be Can-SPAM compliant and must contact us prior to running these for suppression lists. Any partner that doesn't reach out first is considered to be in violation of our terms and conditions.
Coupon/Offer Code Policy - Affiliates may only promote codes that are provided through the Ascend by Partnerize affiliate program. Please note that sales containing a code that is not provided directly by us or is not listed within Ascend by Partnerize may be subject to commission reversals and may result in your removal from the program.
Conversion Point: Valid Form Fill Ages: 18-70 Gender: Any Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $74 per visit for time and travel. GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: - Must be diagnosed with Systemic Lupus Erythematosus (SLE) for 6 months or longer - Cannot have a history of any of the following: Deep vein thrombosis, Pulmonary embolism, Heart attack, Stroke, or Transient ischemic attack (TIA) or mini-stroke - Must be taking medication to treat your lupus symptoms that could include: Oral Corticosteroids (e.g., prednisone, prednisolone), Anti-malarial agents (e.g., chloroquine, hydroxychloroquine), or Conventional immunosuppressants (e.g., mycophenolate mofetil, azathioprine, calcineurin inhibitors, methotrexate) Study Description: The purpose of the APATURA study is to see how effective an investigational medication is at helping to treat Systemic Lupus Erythematosus (SLE). You may be asked to attend 1 screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive the first dose of medication being tested in this study intravenously (through an IV), then the medication will be given as injections every 2 weeks for 6 months. Your total participation will last approximately 10 months and you will be asked to attend two study visits per month during the treatment period and once per month during the follow-up period. You will have the possibility of performing some of these visits remotely from your home, replacing physical office visits. During these visits, you will complete various diagnostic and laboratory tests. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $74 per visit for time and travel. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Ages: 18+ Gender: Any Compensation: Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1300 for their time, in addition to travel support for transportation expenses, lodging, and reimbursement for meals. Study Details: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat Thyroid Eye Disease (TED) associated with Graves’ Disease or Hashimoto Thyroiditis. Travel support will be provided for participants who live outside of the study site area. You may be asked to attend 1 screening visit to determine if you are eligible to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken twice a day for 6 months. After the treatment period, you will continue to be monitored by the study physician for a period of up to two years. Depending on your response to the study drug, you may be given the option to enroll in a follow-up study. There will be 15 study visits where you will complete various procedures and laboratory tests. Participants who qualify for the study will receive trial-related procedures and study medication at no cost and may be compensated up to $1300 for their time, in addition to travel support for transportation expenses, lodging, and reimbursement for meals. The doctor conducting the study will be able to provide you with more information about the study requirements. Qualifications: -Must be diagnosed with either Graves' Disease or Hashimotos Thyroiditis -Experiencing symptoms only for up to a year - not longer - Cannot be diabetic
The user needs to complete the form and be approved in the research study. Patient Profile- Male or Female, 18-85- High risk for Cardiovascular Disease- High risk for High Cholesterol and/or Diabetes Accepts: display target zip codes: 61124/49038/61176/04050/03115/02002/69600/65025/01023/76018/61039/79011/03680/61106/10002/02166/03049/21018/21005/40021/61172/03110/24600/02232/02091/03037
The user needs to complete the form and be approved in the research study. Accepts: display Target: Zip codes: 03037/ 03049/ 79495/18009/02002 Patient Profile • Male or Female, aged 18+ • Reports history of pain in the knee or hip • Body mass index (BMI) less than or equal to 39
The user needs to complete and to be approved in the research study. Patient Profile- Male or Female, 18-85- High risk for Cardiovascular Disease- High risk for High Cholesterol and/or Diabetes Accepts: display target zip codes: B15 2SQ/G20 OSP/L22 0LG/TS19 8PE/G2 0TG/NE46 1QJ/M15 6SX/NE46 1GJ/M15 6SE/CF15 9SS PR7 7NA
Издательство «ДеАгостини» - крупное международное издательство, лидирующее в секторе коллекционных изданий и партворков в России и в мире. Портрет целевой аудитории: Гео – вся РФ. Демография – м/ж, от 3 до 55 лет. Коллекции рассчитаны на широкий круг читателей – детские развивающие серии для детей от 3х лет, коллекционные издания для школьников 8-14 лет, женские журналы – 20-50 лет, мужские коллекционные тематические серии (моделизм, коллекционирование) – 20-55 лет. Преимущества для покупателей: + уникальные издания высокого качества + огромный выбор увлекательных коллекций для всей семьи + возможность оформить подписку на издания и получить дополнительные подарки + удобная доставка по всей РФ (Почта России, пункты самовывоза, курьер) + активное сообщество коллекционеров на официальном форуме и в социальных сетях + отличное обслуживание и обратная связь + возможность накапливать баллы и оплачивать ими покупки в интернет-магазине Преимущества для партнёров: + известный бренд, занимающий лидирующие позиции среди коллекционных изданий и партворков в России + лояльные покупатели + постоянное обновление в каталоге интернет-магазина, удобная подписка на издания + быстрая обработка заказов + хороший средний чек + принимаются все основные виды оплат + основные направления: детские серии и игрушки, журналы для женщин и мужчин, образовательные издания для подростков, моделизм: сборные модели, масштабные модели автомобилей, техника (телескоп, дроид r2-d2 на управлении) и многое другое
"Логомашина учит" — это школа профессий, где образование встречает инновации. Наша миссия – обеспечить специалистов и начинающих профессионалов качественным и доступным образованием, отвечающим современным требованиям рынка труда. Мы предлагаем разнообразные образовательные продукты, включая цифровой дизайн, графический дизайн, SMM, селф-маркетинг, дизайн интерьеров, программирование, диетология, нутрициология и нейросети. Входим в топ-5 лучших школ с точки зрения продукта и образовательного результата и широко известны среди профессиональных дизайнеров. Имеем более 290 тысяч зарегистрированных пользователей и более 100 тысяч членов нашего комьюнити. Больше 60% студентов доходят до конца обучения, а 96% окончивших курс достигают своих целей. Преимущества для клиентов: – 20+ курсов от топовых преподавателей с опытом работы более 15 лет – 70% практики и 30% теории –Индивидуальный подход к каждому – Удобный сервис, поддержка наставников и проверка домашнего задания – Симулятор реальной работы в дизайн-студии – Хакатоны, воркшопы и стажировки для студентов – Карьерная консультация от топовых специалистов – Библиотека бесплатных материалов – Сильное коммьюнити и нетворкинг – Диплом по специальности при прохождении курса – Общение с педагогами в режиме онлайн – Гарантированная стажировка для лучших студентов курса – Возможность покупки курса в рассрочку и удобная оплата – Общение с педагогами в режиме онлайн – Гарантированная стажировка в Логомашине и компаниях-партнерах для лучших студентов курса – Обучение проходят сотрудники крупных компаний – Сбербанк, Сберзвук, ВК, Кошелек, Винлаб, мин.обороны – На связи 24/7 Преимущества для веб-мастеров: – Высокое вознаграждение — 19,2% от суммы покупки клиента – Нет лимитов по сумме комиссии – Высокий средний чек — 90 000 рублей – Высокая конверсия в одобренный заказ — 25% – Больше 70 бесплатных вебинаров ежегодно, с конверсией в продажу до 40% – Комиссия по заказам в рассрочку оплачивается партнеру в полном размере – Курсы под разные сегменты ЦА, что позволяет лучше сегментировать трафик и повышать конверсию – Разрешены почти все виды трафика – Прозрачная статистика в личном кабинете партнера – Уникальные промокоды на скидку 20 000 рублей – Помощь в написании статей по ключевым запросам – Большой выбор рекламных креативов ГЕО РФ + Русскоязычные вне РФ Регионы РФ (если есть) Вся РФ (Исключить: регионы Дагестан, КБР, Осетия, Ингушетия, Чечня , ДНР, ЛНР) Возможна ли рассрочка? Как в таком случае будет рассчитываться вознаграждение партнерам? Полная ставка от суммы полученной от банка после рассрочки (-25%) Средний чек 90 000 р. Условия для передачи статуса партнерам (например, заказ оплачен или доставлен) заказ оплачен / подписана рассрочка Срок хранения cookie (срок привязки пользователя к последнему приведшему партнеру) 30 дней Срок холда 30 дней Возможно ли предоставление именных промокодов для топовых вебмастеров? Да Возможно ли предоставление эксклюзивных условий для топовых вебмастеров? Да Дополнительные материалы https://docs.google.com/spreadsheets/d/1tbAiJIL654cGVPrRh45M9USYw1RAww1fI6TCiZv-8w8/edit#gid=0 Матрица курсов С Уважением, Парнтнерская программа «Логомашина Учит»!